Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial. (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S1474-4422(16)30139-9

PubMed Identifier: 27450474

Publication URI: http://europepmc.org/abstract/MED/27450474

Type: Journal Article/Review

Volume: 15

Parent Publication: The Lancet. Neurology

Issue: 10

ISSN: 1474-4422